One of the most common questions we get centers around the use of anticoagulant drugs—either the brand drug, Coumadin, or the generic version, warfarin—and whether or not an atrial fibrillation patient should be on them. Anticoagulants decrease stroke risk, but can also increase bleeding risk. How do you sort it all out? It's just as …
Read MoreCategory Archives: Anticoagulation
New studies from the Mayo Clinic and the University of Alabama at Birmingham (UAB) show that African Americans are less likely to know they have atrial fibrillation or to be treated with anticoagulants to prevent afib-related strokes, and that stroke deaths are higher among blacks throughout the U.S. and southerners in eight "stroke belt" states. …
Read MoreThere was an update today on the long-awaited FDA status of Atritech's WATCHMAN® device. If approved, it would provide an alternative to taking Coumadin or warfarin to prevent strokes for those with atrial fibrillation. Here are some quotes from the press release. Minneapolis (March 18, 2010) — Atritech, Inc., an emerging medical device company, announced …
Read MoreGenetic tests that show high or low sensitivity to blood thinner (anticoagulant) drugs like warfarin (Coumadin) not only improve dosing accuracy but also reduce hospitalization by 31%, according to a new study just presented at the American College of Cardiology scientific sessions. Coumadin is often prescribed for people who have afib to prevent blood clots …
Read MoreAt Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Russo talked about gender differences in atrial fibrillation treatment, including catheter ablation, as well as women and the risk of stroke from afib. Watch the video: Interview with Dr. Andrea Russo at Boston Atrial Fibrillation Symposium 2010
Read MoreAt Boston Atrial Fibrillation Symposium 2010, Dr. Vivek Reddy shared with us some of the new atrial fibrillation catheter ablation techniques and also talked about non-pharmacological approaches to afib stroke prevention. See the video: Interview with Dr. Vivek Reddy at Boston Atrial Fibrillation Symposium 2010
Read MoreUrgent coordinated action is needed to avoid the thousands of preventable strokes that leave many atrial fibrillation (AF) patients mentally and physically disabled or dead every year. A report, How Can We Avoid a Stroke Crisis?, was launched today in the European Parliament in Brussels by Action for Stroke Prevention, a group of health experts …
Read MoreThis very important story may change how afib patients and their doctors decide if they should be on anticoagulant medications (blood thinners), such as Coumadin or warfarin. The CHADS2 scoring system is how doctors now decide who should be on Coumadin or warfarin to avoid strokes, but a newly-published study adds new stroke risk factors …
Read MoreThe Agency for Healthcare Research and Quality (AHRQ) has introduced a video to help those on anticoagulant drugs, such as Coumadin or warfarin, to use them safely. The video is designed to complement what patients learn from their doctors, pharmacies, or Coumadin clinics. Anticoagulants reduce the risk of stroke in those with atrial fibrillation by …
Read MoreThere is a lot of big news coming out of the European Society of Cardiology (ESC) going on in Barcelona right now. Judging by attendance, this is probably the biggest cardiology event in the world. The big announcement for atrial fibrillation sufferers is the progress towards a replacement for Coumadin (warfarin) coming out of the …
Read More